Owlet has navigated various legal and regulatory challenges, most notably facing intense scrutiny from the U.S. Food and Drug Administration regarding software classifications of its vital-sign tracking algorithms. While the enterprise had to adjust marketing claims and temporarily pull specific app features to comply with federal medical device regulations, it resolved these hurdles by securing formal regulatory clearances rather than facing crippling consumer litigation.